Dysport Posted 2009.05.11 The United States Food & Drug Administration recently approved a competitor to Botox®. Marketed in the United State by Medicis corporation, Dysport™ is a form of botulinum toxin A, abobotulinumtoxinA. The product has been used in Europe for some time but just last week received clearance from the US FDA for marketing in the United States. Initial clinical trials…